Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178553 · ClinicalTrials.gov registry record · Phase 4
Study of Exparel Versus Epidural for Pain Control After Thoracotomy
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT02178553: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02178553 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02178553, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.
Interventions
- DRUG Epidural
- DRUG Intercostal Bupivicaine (Exparel)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2014-10-15 |
| Est. Completion | 2019-01-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02178553
The ClinicalTrials.gov registry entry for NCT02178553 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Epidural is the first listed.
NCT02178553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02178553 about?
NCT02178553 is a clinical study titled "Study of Exparel Versus Epidural for Pain Control After Thoracotomy". Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.
What is the current status of trial NCT02178553?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2014-10-15. Estimated completion is 2019-01-25.
What interventions are being tested in trial NCT02178553?
The interventions under investigation include: Epidural (DRUG), Intercostal Bupivicaine (Exparel) (DRUG).
Who is sponsoring clinical trial NCT02178553?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.